Skip to main content
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1984 Jun;60(704):445–446. doi: 10.1136/pgmj.60.704.445

Does hyperthyroidism predispose to thioridazine-induced hyperpyrexia and cardiac arrhythmias?

M B Murphy, M X FitzGerald
PMCID: PMC2417892  PMID: 6462991

Abstract

Treatment with thioridazine resulted in hyperpyrexia and ventricular tachycardia in a young woman who was later shown to have thyrotoxicosis. The reasons why hyperthyroidism may enhance thioridazine toxicity are reviewed.

Full text

PDF
445

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chouinard G., Ghadirian A. M., Jones B. D. Death attributed to ventricular arrhythmia induced by thioridazine in combination with a single Contac C capsule. Can Med Assoc J. 1978 Oct 7;119(7):729–731. [PMC free article] [PubMed] [Google Scholar]
  2. Giles T. D., Modlin R. K. Death associated with ventricular arrhythmia and thioridazine hydrochloride. JAMA. 1968 Jul 8;205(2):108–110. [PubMed] [Google Scholar]
  3. Haberman M. L. Malignant hyperthermia. An allergic reaction to thioridazine therapy. Arch Intern Med. 1978 May;138(5):800–801. doi: 10.1001/archinte.138.5.800. [DOI] [PubMed] [Google Scholar]
  4. Huston J. R., Bell G. E. The effect of thioridazine hydrochloride and chlorpromazine on the electrocardiogram. JAMA. 1966 Oct 3;198(1):134–138. doi: 10.1001/jama.198.1.134. [DOI] [PubMed] [Google Scholar]
  5. JONES I. H., MEADE T. W. HYPOTHERMIA FOLLOWING CHLORPROMAZINE THERAPY IN MYXOEDEMATOUS PATIENTS. Gerontol Clin (Basel) 1964;55:252–256. doi: 10.1159/000244837. [DOI] [PubMed] [Google Scholar]
  6. Jacknowitz A. I. Thioridazine-induced hyperpyrexia--a case report. Am J Hosp Pharm. 1979 May;36(5):674–678. [PubMed] [Google Scholar]
  7. Kirkpatrick W. E., Lomax P. Temperature changes induced by chlorpromazine and N-methyl chlorpromazine in the rat. Neuropharmacology. 1971 Jan;10(1):61–66. doi: 10.1016/0028-3908(71)90009-8. [DOI] [PubMed] [Google Scholar]
  8. Rosenquist R. J., Brauer W. W., Mork J. N. Recurrent major ventricular arrhythmias associated with thioridazine therapy. Minn Med. 1971 Nov;54(11):877–880. [PubMed] [Google Scholar]
  9. Tse J., Wrenn R. W., Kuo J. F. Thyroxine-induced changes in characteristics and activities of beta-adrenergic receptors and adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate systems in the heart may be related to reputed catecholamine supersensitivity in hyperthyroidism. Endocrinology. 1980 Jul;107(1):6–16. doi: 10.1210/endo-107-1-6. [DOI] [PubMed] [Google Scholar]
  10. Yoon M. S., Han J., Dersham G. H., Jones S. A. Effects of thioridazine (Mellaril) on ventricular electrophysiologic properties. Am J Cardiol. 1979 Jun;43(6):1155–1158. doi: 10.1016/0002-9149(79)90147-4. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES